BioSpace News Archive

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

As Ghana becomes the first country in Africa and globally to approve the University of Oxford’s new malaria vaccine for young children, AIDS Healthcare Foundation (AHF) commends Ghana for its decision and urges the World Health Organization (WHO) to approve the vaccine quickly if current late-stage trials are successful.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented two preclinical poster presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting.

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2023 financial results on Tuesday, May 2, 2023, after the U.S. financial markets close.

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023.

Pulmonx Corporation, a global leader in minimally invasive treatments for lung disease, announced that it will release financial results for the first quarter of 2023 after the close of trading on Tuesday, May 2, 2023.